Symposium on isoproterenol therapy in asthma.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists; D000336:Aerosols / Q000009:adverse effects; D000402:Airway Obstruction / Q000188:drug therapy; D000403:Airway Resistance; D001249:Asthma / Q000188:drug therapy* / Q000401:mortality; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D004837:Epinephrine / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use*; D010627:Phenethylamines / Q000032:analysis; D010656:Phenylephrine / Q000627:therapeutic use; D011656:Pulmonary Emphysema / Q000188:drug therapy; D012123:Pulmonary Ventilation; D012129:Respiratory Function Tests; D012138:Respiratory Therapy
D000319:Adrenergic beta-Antagonists; D000336:Aerosols; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D010627:Phenethylamines; D010656:Phenylephrine; D007545:Isoproterenol; D004837:Epinephrine